---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-091447"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:43:53.327795+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Vir Bio appoints CEO Marianne De Backer to additional role of President

## Summary
- On March 4, 2026, Vir Bio's Board appointed CEO Marianne De Backer to the additional position of President.
- No arrangements or understandings exist between Dr. De Backer and any person regarding her appointment as President.
- No family relationship between Dr. De Backer and any Vir Bio director or executive officer.
- Dr. De Backer has no direct or indirect interest in any transaction requiring Item 404(a) disclosure.

## SEC filing metadata
- accession: 0001193125-26-091447
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000119312526091447/0001193125-26-091447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000119312526091447/d88412d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-091447
- JSON: https://secwatch.observer/filing/0001193125-26-091447.json
- Plain text: https://secwatch.observer/filing/0001193125-26-091447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.